Suchergebnisse - "Lonardo, Amedeo"

PubPharm (259)

1

Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature

enthalten in: Journal of hepatology | 2024

von Lonardo, A. | Bril, F. | Caldwell, S. | +12

2

PRO-C3, liver fibrosis and CKD : The plot thickens

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Lonardo, A.

3

Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases

enthalten in: Nature reviews. Gastroenterology & hepatology | 2024

von Stefan, N. | Lonardo, A. | Targher, G.

4

Clinical Features and Long-Term Outcomes of Patients Diagnosed with MASLD, MAFLD, or Both

enthalten in: Journal of hepatology | 2024

von Zhou, X. | Lonardo, A. | Pan, C. | +60

5

Liver fibrosis : More than meets the eye

enthalten in: Annals of hepatology | 2024

von Lonardo, A.

6

Endpoints in NASH Clinical Trials : Are We Blind in One Eye?

enthalten in: Metabolites | 2024

von Lonardo, A. | Ballestri, S. | Mantovani, A. | +2

7

Shutting those revolving doors

enthalten in: Annals of hepatology | 2023

von Lonardo, A.

8

The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management : a narrative review focusing on principal risk modifiers

enthalten in: Expert review of clinical pharmacology | 2023

von Lonardo, A.

9

Norcholic acid: a novel biomarker of early kidney injury in patients with metabolic dysfunction-associated fatty liver disease

enthalten in: ResearchSquare.com | 2023

von Sun, D. | Xu, C. | Chen, W. | +9

10

Rewriting the natural history of MAFLD on the basis of cardiovascular risk assessment

enthalten in: Nutrition, metabolism, and cardiovascular diseases : NMCD | 2023

von Lonardo, A. | Mantovani, A.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]